Jacob Evans, DO

Instructor, Family Medicine

Jacob Evans
617.414.4830

Biography

In the eleventh grade, my love for travel and health led me to Honduras. I worked for a non-profit organization called Amigos de las Americas, building latrines and giving “charlas” (lessons) pertaining to general health and sanitary measures. I learned that I really enjoyed working with people and teaching them about their bodies and health.

I learned how important our educators are and that teaching is what really inspires me. I enjoy working with the adolescent and pediatric populations. I am completing a UC San Francisco Faculty Development Fellowship Program to help better teach these students and residents.

I believe it is my responsibility to teach my patients about their bodies and about any disease process going on within them, as well as teaching them that exercise and eating healthy is one of the recipes to preventing and fighting illness, and in making the aging process an easier one. As an avid sports aficionado, I have a personal interest in sports medicine and I believe that exercise is medicine.

I believe that the human body has a great ability to self-heal and it is my job to help bring the body as close to its ideal mechanics as possible to allow itself to heal. Although I do not practice osteopathic manipulation in my practice, I do believe in its principles and that it has great application for most patients with musculoskeletal and non-musculoskeletal issues. Although there is a time and place for narcotic medications, I don’t believe in the use of narcotics for the treatment of long-term chronic pain. I believe in the practice of complimentary and alternative medicine to help create homeostasis in the body.

I teach medical students in my clinical practice and am proud to be faculty for our Family Medicine Residency program starting July 2018. With this new role, I will be training Family Physicians of the future.

Other Positions

  • Kaiser Permanente San Jose Medical Center

Education

  • Touro College, DO
  • University of California, San Diego, BS

Publications

  • Published on 8/1/2000

    Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. J Clin Pharmacol. 2000 Aug; 40(8):854-60. PMID: 10934669.

    Read at: PubMed
  • Published on 12/15/1999

    Watkins MT, Patton GM, Soler HM, Albadawi H, Humphries DE, Evans JE, Kadowaki H. Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase. Biochem J. 1999 Dec 15; 344 Pt 3:747-54. PMID: 10585861.

    Read at: PubMed
  • Published on 9/1/1997

    Durso R, Evans JE, Josephs E, Szabo GK, Evans BA, Handler JS, Jennings D, Browne TR. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. Ann Neurol. 1997 Sep; 42(3):300-4. PMID: 9307250.

    Read at: PubMed
  • Published on 1/1/1993

    Browne TR, Szabo GK, McEntegart C, Evans JE, Evans BA, Miceli JJ, Quon C, Dougherty CL, Kres J, Davoudi H. Bioavailability studies of drugs with nonlinear pharmacokinetics: II. Absolute bioavailability of intravenous phenytoin prodrug at therapeutic phenytoin serum concentrations determined by double-stable isotope technique. J Clin Pharmacol. 1993 Jan; 33(1):89-94. PMID: 8429121.

    Read at: PubMed
  • Published on 12/1/1992

    Browne TR, Szabo GK, Schumacher GE, Greenblatt DJ, Evans JE, Evans BA. Bioavailability studies of drugs with nonlinear pharmacokinetics: I. Tracer dose AUC varies directly with serum concentration. J Clin Pharmacol. 1992 Dec; 32(12):1141-5. PMID: 1487554.

    Read at: PubMed
  • Published on 8/1/1990

    Browne TR, Greenblatt DJ, Schumacher GE, Szabo GK, Evans JE, Evans BA. New pharmacokinetic methods. III. Two simple test for "deep pool effect". J Clin Pharmacol. 1990 Aug; 30(8):680-5. PMID: 2401747.

    Read at: PubMed
  • Published on 7/1/1990

    Browne TR, Szabo GK, Walsh CT, Schumacher GE, Evans JE, Evans BA. New pharmacokinetic methods. II: Determination of the presence or absence of product inhibition in drugs with nonlinear pharmacokinetics. J Clin Pharmacol. 1990 Jul; 30(7):578-84. PMID: 2391390.

    Read at: PubMed
  • Published on 6/1/1990

    Browne TR, Greenblatt DJ, Szabo GK, Evans JE, Evans BA. New pharmacokinetic methods: I. Estimation of mean serum concentration from trough serum concentration. J Clin Pharmacol. 1990 Jun; 30(6):482-8. PMID: 2355100.

    Read at: PubMed
  • Published on 1/1/1989

    Browne TR, Davoudi H, Donn KH, Dougherty CL, Dukes GE, Evans B, Evans JE, Jamerson B, Kres J, McEntegart CM, et al. Bioavailability of ACC-9653 (phenytoin prodrug). Epilepsia. 1989; 30 Suppl 2:S27-32. PMID: 2670536.

    Read at: PubMed
  • Published on 7/1/1988

    Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, Mikati MA. Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance. Neurology. 1988 Jul; 38(7):1146-50. PMID: 3386835.

    Read at: PubMed

View 2 more publications: View full profile at BUMC

View all profiles